ozempic glp-1 Ozempic® (semaglutide) RA for Type 2 Diabetes GLP-1 Weight Loss Medication Guide:

Eli Lilly said the oral GLP-1 pill has been shown to reduce hemoglobin A1C levels -- a blood test that shows average blood sugar levels over two to three months -- by an average of 1.3% to 1.8% in people with diabetes

Iwaya C., Nomiyama T., Komatsu S., et al., Exendin4, a Glucagonlike Peptide1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NFB Activation, Endocrinology 158 (2017): 42184232

Clinical trials have not established a direct causal relationship between these medications and nocturnal hyperhidrosis

There were no unexpected safety issues with semaglutide

The Heart Disease Study of Semaglutide in Patients with Type 2 Diabetes (SOUL) is a more extensive and extended phase 3 CVOT presently being conducted, and results are expected in 2024 [55]